Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)
Others
Ratios

Bioadaptives (BDPT) Other Operating Expenses (2019 - 2025)

Historic Other Operating Expenses for Bioadaptives (BDPT) over the last 7 years, with Q3 2025 value amounting to $18569.0.

  • Bioadaptives' Other Operating Expenses fell 7722.85% to $18569.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $285442.0, marking a year-over-year increase of 3254.24%. This contributed to the annual value of $270814.0 for FY2024, which is 9587.02% up from last year.
  • According to the latest figures from Q3 2025, Bioadaptives' Other Operating Expenses is $18569.0, which was down 7722.85% from $82390.0 recorded in Q2 2025.
  • In the past 5 years, Bioadaptives' Other Operating Expenses registered a high of $207758.0 during Q1 2021, and its lowest value of $8919.0 during Q1 2023.
  • For the 5-year period, Bioadaptives' Other Operating Expenses averaged around $61506.6, with its median value being $63157.0 (2023).
  • Per our database at Business Quant, Bioadaptives' Other Operating Expenses surged by 66283.55% in 2021 and then crashed by 8743.79% in 2023.
  • Bioadaptives' Other Operating Expenses (Quarter) stood at $63384.0 in 2021, then crashed by 82.79% to $10911.0 in 2022, then skyrocketed by 113.21% to $23263.0 in 2023, then skyrocketed by 238.38% to $78718.0 in 2024, then tumbled by 76.41% to $18569.0 in 2025.
  • Its Other Operating Expenses was $18569.0 in Q3 2025, compared to $82390.0 in Q2 2025 and $105765.0 in Q1 2025.